Pharmaceutical company Ranbaxy Laboratories Ltd it has transferred its new drug discovery research unit (NDDR) to Daiichi Sankyo India Pharma Pvt Ltd as part of strengthening global research and development structure of the group.
"The new organisation RCI, based in Gurgaon, will play a key role in the group's global drug discovery research," Ranbaxy said in a statement.
As part of the transfer, Ranbaxy's new drug discovery research will be renamed as Daiichi Sankyo Life Science Research Center (RCI), which will be under Daiichi Sankyo India Pharma.
On Friday, Ranbaxy shares closed 1% down at Rs456 on the Bombay Stock Exchange, while the Sensex ended at 0.28% down at 17,460 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
